Keep your chin up. It's true there are many disgusting characters surrounding this company but the fundamental financial strength is undeniable, I have never heard of a very profitable small/tiny Biotech worth only $350 Million (cash removed) making and growing profits like this while nearly completing recruitment for a blockbuster Phase 3 without needing to profit share with Big pharma? The P/E of 14 is wild, it's cheap for their current growth on tiny EPP with everything else for free! If they get to EPS $0.8 in 3 months time then that is a larger EPS than Pro Medicus with their P/E of 250+ have right now according to my Nabtrade which lists it as $0.791 for PME. Clinuvel just need to execute that buyback well, don't nibble away but take some serious liquidity away - once again look at PME they have bought back $6.5 Million of shares in just days and they don't even have as much cash as Clinuvel but are showing great support to their shareholders despite having a P/E 20 times higher.
All IMO DYOR
CUV Price at posting:
$11.27 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)